Lorazepam

Product NDC: 63304-772
11-digit product format: 633040772
Labeler code: 63304
Product ID: 63304-772_b8fbb599-96d9-4866-908d-d8be424e5ee3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lorazepam
Dosage form: TABLET
Route: ORAL
Labeler: SUN PHARMACEUTICAL INDUSTRIES INC
Application: ANDA076045
Marketing category: ANDA
Marketing start: 2023-06-25
Substance: LORAZEPAM
Active strength: .5 mg/1
Pharmacologic classes: Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-772-05	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-772-30	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-772-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-772-10	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-772-90	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-772-05	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-772-30	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-772-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-772-10	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-772-90	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-772-05	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-772-30	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-772-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-772-10	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-772-90	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-772-05	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-772-30	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-772-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-772-10	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-772-90	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-772-05	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-772-30	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-772-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-772-10	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-772-90	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	63304-772-05	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	63304-772-30	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	63304-772-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	63304-772-10	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	63304-772-90	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	63304-772-90	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	63304-772-05	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	63304-772-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	63304-772-01	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	63304-772-10	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A076045-001	LORAZEPAM	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29
A076045-002	LORAZEPAM	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29
A076045-003	LORAZEPAM	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A076045-001	AB
A076045-002	AB
A076045-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076045-002	LORAZEPAM	1MG	TABLET / ORAL	AB	2001-08-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076045-003	LORAZEPAM	2MG	TABLET / ORAL	AB	2001-08-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076045-001	LORAZEPAM	0.5MG	TABLET / ORAL	AB	2001-08-29	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 63 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A076045-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076045-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076045-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076045-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076045-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076045-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076045-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076045-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076045-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076045-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076045-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076045-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076045-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076045-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076045-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076045-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076045-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076045-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076045-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076045-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076045-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076045-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076045-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076045-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076045-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076045-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076045-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076045-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076045-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076045-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076045-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076045-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076045-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076045-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076045-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076045-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076045-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076045-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076045-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076045-001	AB	1	`1e350fbaab3a…`

Additional Listing Data#

Finished product: Yes
Brand name base: Lorazepam
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LORAZEPAM	.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
O26FZP769L	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197900	Internal RxNorm lookup
197901	Internal RxNorm lookup
197902	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0c1caa9c-9ef1-459c-86c3-adb939130a9f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a759f740-8682-4896-9194-8b6c103c9aee	Product name	3	20250716
b7badb1c-6d3f-4f95-a4ca-ce69992e58a1	Product name	1	20220308
5d98a0ba-a64b-d9b2-e6ec-87edbb57a285	Product name	2	20180320
ac8efea8-f412-295f-00ce-b095e5cbc115	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
63304-772-01	2023-07-06	Lorazepam Tablets, USP CIV
63304-772-05	2023-07-06	Lorazepam Tablets, USP CIV
63304-772-10	2023-07-06	Lorazepam Tablets, USP CIV
63304-772-30	2023-07-06	Lorazepam Tablets, USP CIV
63304-772-90	2023-07-06	Lorazepam Tablets, USP CIV
63304-772-01	2020-01-31	Lorazepam Tablets, USP CIV
63304-772-05	2020-01-31	Lorazepam Tablets, USP CIV
63304-772-10	2020-01-31	Lorazepam Tablets, USP CIV
63304-772-30	2020-01-31	Lorazepam Tablets, USP CIV
63304-772-90	2020-01-31	Lorazepam Tablets, USP CIV

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63304-772-01	Lorazepam	100 in 1 BOTTLE	TABLET	100	4
63304-772-05	Lorazepam	500 in 1 BOTTLE	TABLET	500	4
63304-772-10	Lorazepam	1000 in 1 BOTTLE	TABLET	1000	4
63304-772-90	Lorazepam	90 in 1 BOTTLE	TABLET	90	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63304-772-01	EA - Each	63304-772	17f34372-fe50-43d2-8bf6-9ac82f69f753	1	2012-07-24
63304-772-05	EA - Each	63304-772	12a9e0b0-c415-4aec-88e8-83f5d133916b	1	2012-07-24
63304-772-90	EA - Each	63304-772	8729030d-12a9-41cf-a41d-dce5221a07e3	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LORAZEPAM	ACTIVE INGREDIENT	O26FZP769L	LORAZEPAM TABLET [TYA PHARMACEUTICALS]	4
LORAZEPAM	ACTIVE MOIETY	O26FZP769L	LORAZEPAM TABLET [TYA PHARMACEUTICALS]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LORAZEPAM TABLET [TYA PHARMACEUTICALS]	4
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	LORAZEPAM TABLET [TYA PHARMACEUTICALS]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LORAZEPAM TABLET [TYA PHARMACEUTICALS]	4
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	LORAZEPAM TABLET [TYA PHARMACEUTICALS]	4
LORAZEPAM	ACTIVE INGREDIENT	O26FZP769L	LORAZEPAM TABLET [RANBAXY PHARMACEUTICALS INC.]	3
LORAZEPAM	ACTIVE MOIETY	O26FZP769L	LORAZEPAM TABLET [RANBAXY PHARMACEUTICALS INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LORAZEPAM TABLET [RANBAXY PHARMACEUTICALS INC.]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	LORAZEPAM TABLET [RANBAXY PHARMACEUTICALS INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LORAZEPAM TABLET [RANBAXY PHARMACEUTICALS INC.]	3
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	LORAZEPAM TABLET [RANBAXY PHARMACEUTICALS INC.]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63304-772	LORAZEPAM TABLET [SUN PHARMACEUTICAL INDUSTRIES INC]	4	Current NDC, Legacy NDC, 4 package rows	20230707_0c1caa9c-9ef1-459c-86c3-adb939130a9f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lorazepam	LORAZEPAM	PD-Rx Pharmaceuticals, Inc.	1f79a5a1-0c40-45cf-8994-51f5ba3a5938	2025-10-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	REMEDYREPACK INC.	86630bdd-13ad-4ab5-9e94-fcf2ea2113e1	2025-10-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	PD-Rx Pharmaceuticals, Inc.	08a30230-fc95-9025-e063-6394a90ae21b	2025-08-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	17919c82-87f2-5030-e063-6294a90ac91a	2025-04-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	1791d5c9-9004-5c4b-e063-6294a90adf3d	2025-04-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	NuCare Pharmaceuticals, Inc.	29f63525-2839-946c-e063-6294a90aebb1	2024-12-23	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	Asclemed USA, Inc.	ebdf72f7-7462-4b83-81b4-c7988860c728	2024-11-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	1bcf608a-11c1-ec7d-e063-6394a90ab710	2024-06-26	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	82f79757-69f0-4a37-93a6-55b66ae86ad7	2024-02-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	0ce02d7d-d855-c73f-e063-6294a90abe93	2023-12-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045
Lorazepam	LORAZEPAM	SUN PHARMACEUTICAL INDUSTRIES INC	0c1caa9c-9ef1-459c-86c3-adb939130a9f	2023-06-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076045 application number: ANDA076045 ndc (product): 63304-772

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O26FZP769L	LORAZEPAM	846-49-1	LORAZEPAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197900	LORazepam 0.5 MG Oral Tablet	PSN	08a30230-fc95-9025-e063-6394a90ae21b	16
197901	LORazepam 1 MG Oral Tablet	PSN	08a30230-fc95-9025-e063-6394a90ae21b	16
197902	LORazepam 2 MG Oral Tablet	PSN	08a30230-fc95-9025-e063-6394a90ae21b	16
197900	lorazepam 0.5 MG Oral Tablet	SCD	08a30230-fc95-9025-e063-6394a90ae21b	16
197901	lorazepam 1 MG Oral Tablet	SCD	08a30230-fc95-9025-e063-6394a90ae21b	16
197902	lorazepam 2 MG Oral Tablet	SCD	08a30230-fc95-9025-e063-6394a90ae21b	16
197900	LORazepam 0.5 MG Oral Tablet	PSN	0c1caa9c-9ef1-459c-86c3-adb939130a9f	4
197900	LORazepam 0.5 MG Oral Tablet	PSN	0a145ba5-be21-49c4-a036-baa81c88e5f2	4
197901	LORazepam 1 MG Oral Tablet	PSN	0c1caa9c-9ef1-459c-86c3-adb939130a9f	4
197901	LORazepam 1 MG Oral Tablet	PSN	0a145ba5-be21-49c4-a036-baa81c88e5f2	4
197902	LORazepam 2 MG Oral Tablet	PSN	0c1caa9c-9ef1-459c-86c3-adb939130a9f	4
197900	lorazepam 0.5 MG Oral Tablet	SCD	0c1caa9c-9ef1-459c-86c3-adb939130a9f	4
197900	lorazepam 0.5 MG Oral Tablet	SCD	0a145ba5-be21-49c4-a036-baa81c88e5f2	4
197901	lorazepam 1 MG Oral Tablet	SCD	0c1caa9c-9ef1-459c-86c3-adb939130a9f	4
197901	lorazepam 1 MG Oral Tablet	SCD	0a145ba5-be21-49c4-a036-baa81c88e5f2	4
197902	lorazepam 2 MG Oral Tablet	SCD	0c1caa9c-9ef1-459c-86c3-adb939130a9f	4
197900	LORazepam 0.5 MG Oral Tablet	PSN	0ce02d7d-d855-c73f-e063-6294a90abe93	1
197900	LORazepam 0.5 MG Oral Tablet	PSN	ebdf72f7-7462-4b83-81b4-c7988860c728	1
197900	LORazepam 0.5 MG Oral Tablet	PSN	29f63525-2839-946c-e063-6294a90aebb1	1
197901	LORazepam 1 MG Oral Tablet	PSN	ebdf72f7-7462-4b83-81b4-c7988860c728	1
197902	LORazepam 2 MG Oral Tablet	PSN	ebdf72f7-7462-4b83-81b4-c7988860c728	1
197900	lorazepam 0.5 MG Oral Tablet	SCD	29f63525-2839-946c-e063-6294a90aebb1	1
197900	lorazepam 0.5 MG Oral Tablet	SCD	0ce02d7d-d855-c73f-e063-6294a90abe93	1
197900	lorazepam 0.5 MG Oral Tablet	SCD	ebdf72f7-7462-4b83-81b4-c7988860c728	1
197901	lorazepam 1 MG Oral Tablet	SCD	ebdf72f7-7462-4b83-81b4-c7988860c728	1
197902	lorazepam 2 MG Oral Tablet	SCD	ebdf72f7-7462-4b83-81b4-c7988860c728	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
63304-772-01	63304077201	100 TABLET in 1 BOTTLE (63304-772-01)	100 tablet	2023-06-25	No	No	Current
63304-772-05	63304077205	500 TABLET in 1 BOTTLE (63304-772-05)	500 tablet	2023-06-25	No	No	Current
63304-772-10	63304077210	1000 TABLET in 1 BOTTLE (63304-772-10)	1000 tablet	2023-06-25	No	No	Current
63304-772-90	63304077290	90 TABLET in 1 BOTTLE (63304-772-90)	90 tablet	2023-06-25	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lorazepam Tablets, USP CIV	PD-Rx Pharmaceuticals, Inc.	2025-08-05	HUMAN PRESCRIPTION DRUG LABEL	16
Lorazepam Tablets, USP CIV	NuCare Pharmaceuticals, Inc.	2024-12-23	HUMAN PRESCRIPTION DRUG LABEL	1
Lorazepam Tablets, USP CIV	Asclemed USA, Inc. \| ASCLEMED USA INC. DBA ENOVACHEM	2024-11-05	HUMAN PRESCRIPTION DRUG LABEL	1
Lorazepam Tablets, USP CIV	Aphena Pharma Solutions - Tennessee, LLC	2023-12-19	HUMAN PRESCRIPTION DRUG LABEL	1
Lorazepam Tablets, USP CIV	SUN PHARMACEUTICAL INDUSTRIES INC \| Ohm Laboratories Inc.	2023-06-30	HUMAN PRESCRIPTION DRUG LABEL	4
C-IV Rx only LORAZEPAM TABLETS, USP	TYA Pharmaceuticals	2013-04-11	HUMAN PRESCRIPTION DRUG LABEL	4